Book of Wisdom

SOPHiA GENETICS Reports First Quarter 2024 Results

Retrieved on: 
Martedì, Maggio 7, 2024
Liquid biopsy, Table, Mayo Clinic, Cancer, NHS, Health equity, COVID, Average cost, Book of Wisdom, Breast cancer, FY, GENETICS, Traction, Sophia Genetics, Research, Forecasting, Growth, SOPHIA, NGS, Public expenditure, Algorithm, Patient, MSK, Eastern Time Zone, Acquisition, Medicine, Pension, COVID-19, AstraZeneca, Constant, Central European Time, Pharmaceutical industry

BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2024.

Key Points: 
  • BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2024.
  • SOPHiA GENETICS will host a conference call and live webcast to discuss the first quarter 2024 results on Tuesday, May 7, 2024, at 8:00 a.m. (08:00) Eastern Time / 2:00 p.m. (14:00) Central European Time.
  • The call will be webcast live on the SOPHiA GENETICS Investor Relations website, ir.sophiagenetics.com.
  • Additionally, an audio replay of the conference call will be available on the SOPHiA GENETICS website after its completion.

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Martedì, Marzo 5, 2024
Acquisition, MSK, Forecasting, Constant, Sophia Genetics, Pension, Average cost, Growth, Table, NGS, Book of Wisdom, DASA, Liquid biopsy, COVID-19, Eastern Time Zone, Recombinant DNA, HRD, COVID, Neoplasm, Patient, Public expenditure, Platform, FY, Genomics, Microsoft, Research, GENETICS, Cancer, Central European Time, Pharmaceutical industry

BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for its fourth quarter and fiscal year ended December 31, 2023.

Key Points: 
  • BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for its fourth quarter and fiscal year ended December 31, 2023.
  • SOPHiA GENETICS will host a conference call and live webcast to discuss the fourth quarter and full year 2023 results, and financial guidance for the full year 2024 on Tuesday, March 5, 2024, at 8:00 a.m. (08:00) Eastern Time / 2:00 p.m. (14:00) Central European Time.
  • Additionally, an audio replay of the conference call will be available on the SOPHiA GENETICS website after its completion.
  • These non-IFRS measures are key measures used by SOPHiA GENETICS management and board of directors to evaluate its operating performance and generate future operating plans.

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023

Retrieved on: 
Martedì, Novembre 7, 2023
Average cost, AstraZeneca, Operating cost, Book of Wisdom, MSK, Organization, Sophia Genetics, CLB, Growth, Central European Time, COVID, Sophia, Neoplasm, COVID-19, Health equity, Marketing, Partnership, Forecasting, Liquid biopsy, Integration, Constant, Eastern Time Zone, GENETICS, Pharmaceutical industry, Video game, Medical imaging

BOSTON and ROLLE, Switzerland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for the third quarter ended September 30, 2023.

Key Points: 
  • BOSTON and ROLLE, Switzerland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for the third quarter ended September 30, 2023.
  • Cash burn for the third quarter of 2023 was $15.8 million, compared to $27.4 million in the third quarter of 2022.
  • R&D expenses for the third quarter of 2023 were $9.0 million compared to $10.1 million for the third quarter of 2022.
  • SOPHiA GENETICS will host a conference call and live webcast to discuss the third quarter of 2023 financial results as well as business outlook on Tuesday, November 7, 2023, at 8:00 a.m. (08:00) Eastern Time / 2:00 p.m. (14:00) Central European Time.

How to Play the Game of Life - Beginner Version by Tim Doyle now available in Print and Kindle

Retrieved on: 
Mercoledì, Marzo 15, 2023
Learning, Heart, UFO, Mind, OOBE, Dream, Astrology, Oneness, Teaching, Meditation, The Golden One (novel), Arcturian (album), Echinopsis pachanoi, Book of Wisdom, Student, Life, Consciousness, Comprehension, Path, Timothy, Universal mind, Nursing, Print, Kindle

CHESAPEAKE BEACH, Md., March 15, 2023 /PRNewswire-PRWeb/ -- Timothy J Doyle is a spiritual guide who shares the channeled teachings of The Golden Ones based on universal laws and principles of harmony, balance, order, and unity for the greater good.

Key Points: 
  • How to Play the Game of Life – Beginner Version is the first book of teaching from The Golden Ones.
  • The book is now available in Print and Kindle versions.
  • Tim explains, "The Golden Ones are Co-Creator Gods and administrators of this Earth as a Spiritual Training School.
  • How to Play the Game of Life – Beginner Version is the first book of teaching from The Golden Ones.